{"id":4211,"date":"2026-06-09T14:36:20","date_gmt":"2026-06-09T05:36:20","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/member_search\/4211"},"modified":"2026-06-09T14:37:02","modified_gmt":"2026-06-09T05:37:02","slug":"Hui-Ching-Wang","status":"publish","type":"researcher","link":"https:\/\/atlas.ncc.go.jp\/en\/member_search\/4211\/","title":{"rendered":"Hui-Ching Wang EN"},"template":"","class_list":["post-4211","researcher","type-researcher","status-publish","hentry","en-US"],"acf":{"name_eg":"Hui-Ching Wang","familyName_eg":"Wang","has_jp_name":false,"name_jp":"","researcher_photo":4198,"participated_in":["1"],"degree":"MD, PhD","position":"Associate Professor; Attending Physician, Division of Hematology & Oncology","eg_position":"Associate Professor; Attending Physician, Division of Hematology & Oncology","facilities":4205,"department":[],"speciality":"","eg_speciality":"Head and Neck Cancer; Hematologic Malignancies; Gastrointestinal Cancer; Immunotherapy; Targeted Therapy; Early Phase Clinical Trials","background":"

Dr. Hui-Ching Wang's Story<\/h2>\r\n

I am a physician-scientist specializing in hematology and oncology at Kaohsiung Medical University Chung-Ho Memorial Hospital in Taiwan. My clinical and research work spans hematologic malignancies, head and neck squamous cell carcinoma (HNSCC), and gastrointestinal cancers. As an ATLAS Board National Principal Investigator, I am committed to advancing Asia-wide collaborative clinical trials and translational research. My goal is to bridge molecular insights with clinical practice to develop biomarker-driven, patient-tailored treatment strategies that can improve outcomes for patients across Asia.<\/p>\r\n

Research Interest<\/h2>\r\n

My primary research focuses on head and neck squamous cell carcinoma (HNSCC) and hematologic malignancies, with emphasis on early-phase clinical trials and translational oncology. I utilize multi-omics approaches\u2014including genomic mutation signatures and tumor mutation burden analysis\u2014to identify predictive biomarkers for treatment response in immunotherapy and chemoradiotherapy. I am also interested in tumor microenvironment characterization, chromatin remodeling, and immune-related signatures to improve patient stratification. Additionally, I actively participate in international collaborations to facilitate novel therapeutic strategies and precision medicine approaches for patients in Asia and globally.<\/p>\r\n

Qualifications, certified physicians, medical specialists, etc.<\/h2>\r\n

Board of Medical Oncology, Taiwan (No.105003, 2016); Board of Hematology, Taiwan (No.105436, 2015); Board of Hematopoietic Transplantation, Taiwan (No.104181, 2015); Board of Internal Medicine, Taiwan (No.009778, 2013); Taiwan Medical License (No.046086, 2010)<\/p>\r\n

Specialized field<\/h2>\r\n

Medical Oncology; Hematology; Head and Neck Cancer; Translational Research; Precision Medicine; Clinical Trials<\/p>\r\n

Professional Experience<\/h2>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
2014\u2013present<\/th>\r\nAttending Physician, Division of Hematology & Oncology, Kaohsiung Medical University Chung-Ho Memorial Hospital<\/td>\r\n<\/tr>\r\n
\u00a02023\u2013present<\/th>\r\nAssociate Professor, Department of Medicine, College of Medicine, Kaohsiung Medical University<\/td>\r\n<\/tr>\r\n
2020\u20132023<\/th>\r\nAssistant Professor, Department of Medicine, College of Medicine, Kaohsiung Medical University<\/td>\r\n<\/tr>\r\n
2013-2014<\/th>\r\nChief Resident, Department of Internal Medicine; Fellow, Division of Hematology-Oncology, Kaohsiung Medical University Hospital<\/td>\r\n<\/tr>\r\n
2010-2013<\/th>\r\nResident, Department of Internal Medicine, Kaohsiung Medical University Hospital<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>","eg_background":"

Dr. Hui-Ching Wang's Story<\/h2>\r\n

I am a physician-scientist specializing in hematology and oncology at Kaohsiung Medical University Chung-Ho Memorial Hospital in Taiwan. My clinical and research work spans hematologic malignancies, head and neck squamous cell carcinoma (HNSCC), and gastrointestinal cancers. As an ATLAS Board National Principal Investigator, I am committed to advancing Asia-wide collaborative clinical trials and translational research. My goal is to bridge molecular insights with clinical practice to develop biomarker-driven, patient-tailored treatment strategies that can improve outcomes for patients across Asia.<\/p>\r\n

Research Interest<\/h2>\r\n

My primary research focuses on head and neck squamous cell carcinoma (HNSCC) and hematologic malignancies, with emphasis on early-phase clinical trials and translational oncology. I utilize multi-omics approaches\u2014including genomic mutation signatures and tumor mutation burden analysis\u2014to identify predictive biomarkers for treatment response in immunotherapy and chemoradiotherapy. I am also interested in tumor microenvironment characterization, chromatin remodeling, and immune-related signatures to improve patient stratification. Additionally, I actively participate in international collaborations to facilitate novel therapeutic strategies and precision medicine approaches for patients in Asia and globally.<\/p>\r\n

Qualifications, certified physicians, medical specialists, etc.<\/h2>\r\n

Board of Medical Oncology, Taiwan (No.105003, 2016); Board of Hematology, Taiwan (No.105436, 2015); Board of Hematopoietic Transplantation, Taiwan (No.104181, 2015); Board of Internal Medicine, Taiwan (No.009778, 2013); Taiwan Medical License (No.046086, 2010)<\/p>\r\n

Specialized field<\/h2>\r\n

Medical Oncology; Hematology; Head and Neck Cancer; Translational Research; Precision Medicine; Clinical Trials<\/p>\r\n

Professional Experience<\/h2>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
2014\u2013present<\/th>\r\nAttending Physician, Division of Hematology & Oncology, Kaohsiung Medical University Chung-Ho Memorial Hospital<\/td>\r\n<\/tr>\r\n
\u00a02023\u2013present<\/th>\r\nAssociate Professor, Department of Medicine, College of Medicine, Kaohsiung Medical University<\/td>\r\n<\/tr>\r\n
2020\u20132023<\/th>\r\nAssistant Professor, Department of Medicine, College of Medicine, Kaohsiung Medical University<\/td>\r\n<\/tr>\r\n
2013-2014<\/th>\r\nChief Resident, Department of Internal Medicine; Fellow, Division of Hematology-Oncology, Kaohsiung Medical University Hospital<\/td>\r\n<\/tr>\r\n
2010-2013<\/th>\r\nResident, Department of Internal Medicine, Kaohsiung Medical University Hospital<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>","researcher_outerlink1":"https:\/\/orcid.org\/0000-0002-8232-0387","researcher_outerlink2":"","researcher_outerlink3":"","researcher_outerlink4":"","researcher_outerlink5":"","is_retired":false},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher\/4211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/researcher"}],"acf:post":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/facility\/4205"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=4211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}